CURI Should I Buy

BUY now for a beginner long-term investor (with the expectation of higher-than-average volatility). CURI is showing improving fundamentals (2025/Q3 strong revenue growth and better gross margin), bullish near-term technical momentum (MACD expanding above zero), and options positioning that leans bullish on open interest. Price is sitting just below near-term resistance (R1 ~3.84); a clean push above ~3.84–3.93 would confirm a breakout. No Intellectia signals today, but the setup is still favorable enough to justify an entry now rather than waiting.

Trend/Momentum: MACD histogram is positive (0.0488) and expanding, signaling strengthening upward momentum. RSI(6) at ~65 is neutral-to-slightly-warm (not overbought), consistent with a rising move that hasn’t fully overheated yet. Moving averages are converging, which often precedes a larger directional move; current momentum tilts bullish. Key levels: Pivot 3.695 is the main line to hold for the short-term uptrend. Immediate resistance is R1 3.84 (price ~3.81 post-market), then R2 3.93. Supports are S1 3.549 and S2 3.459. Read-through: With price near 3.84 resistance, the chart suggests a breakout attempt; if price holds above ~3.70, the bullish bias remains intact.